• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钍造影剂诱发的肝血管肉瘤,以及同一患者同时发生的肝细胞癌和胆管癌。

Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient.

作者信息

Kojiro M, Kawano Y, Kawasaki H, Nakashima T, Ikezaki H

出版信息

Cancer. 1982 May 15;49(10):2161-4. doi: 10.1002/1097-0142(19820515)49:10<2161::aid-cncr2820491029>3.0.co;2-m.

DOI:10.1002/1097-0142(19820515)49:10<2161::aid-cncr2820491029>3.0.co;2-m
PMID:6280835
Abstract

A 64-year-old man developed hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma, 36 years after Thorotrast administration. The patient presented with a large mass in the right upper quadrant. His serum alpha-fetoprotein increased from 800 ng/ml to 51.2 micrograms/ml, and liver biopsy disclosed hepatocellular carcinoma. At autopsy, the liver had two different malignant neoplasms; angiosarcoma and combined hepatocellular and cholangiocarcinoma. Metastases of angiosarcoma to both lungs and of cholangiocarcinoma to periaortic lymph nodes were also seen. Interestingly, some neoplastic cells of angiosarcoma exhibited globular hyaline inclusions, which were Periodic-Acid-Schiff reaction positive and diastase-resistant.

摘要

一名64岁男性在注射钍胶体36年后发生了肝血管肉瘤,并合并肝细胞癌和胆管癌。患者右上腹出现一个大肿块。他的血清甲胎蛋白从800 ng/ml升至51.2μg/ml,肝脏活检显示为肝细胞癌。尸检时,肝脏有两种不同的恶性肿瘤;血管肉瘤和肝细胞癌合并胆管癌。还发现血管肉瘤转移至双肺,胆管癌转移至主动脉旁淋巴结。有趣的是,血管肉瘤的一些肿瘤细胞呈现球形透明包涵体,对高碘酸-希夫反应呈阳性且耐淀粉酶。

相似文献

1
Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient.钍造影剂诱发的肝血管肉瘤,以及同一患者同时发生的肝细胞癌和胆管癌。
Cancer. 1982 May 15;49(10):2161-4. doi: 10.1002/1097-0142(19820515)49:10<2161::aid-cncr2820491029>3.0.co;2-m.
2
[Hepatic cholangiocarcinoma and angiosarcoma after the administration of thorotrast].
Med Clin (Barc). 1985 Oct 19;85(12):516.
3
Thorotrast induced hepatic cholangiocarcinoma and angiosarcoma.钍造影剂诱发肝内胆管癌和血管肉瘤。
Hum Pathol. 1979 Jan;10(1):108-12. doi: 10.1016/s0046-8177(79)80079-9.
4
[Hepatic angiosarcoma and cholangiocarcinoma in a patient with thorotrast deposits].
Med Clin (Barc). 1985 Mar 9;84(9):363-5.
5
Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma.102例钍造影剂相关肝细胞癌、胆管癌和肝血管肉瘤的病理形态学特征
Cancer. 1988 Sep 15;62(6):1153-62. doi: 10.1002/1097-0142(19880915)62:6<1153::aid-cncr2820620619>3.0.co;2-i.
6
Thorotrast-induced hepatosplenic neoplasia: CT identification.
AJR Am J Roentgenol. 1986 May;146(5):997-1004. doi: 10.2214/ajr.146.5.997.
7
Thorotrast-associated hepatic leiomyosarcoma and cholangiocarcinoma in a single patient.钍造影剂相关的肝平滑肌肉瘤和胆管癌并存于同一患者。
Hum Pathol. 1987 May;18(5):524-6. doi: 10.1016/s0046-8177(87)80039-4.
8
[Double liver tumors following intravenous thorotrast injection].[静脉注射钍造影剂后出现的双肝肿瘤]
Verh Dtsch Ges Pathol. 1978;62:480.
9
On the histopathology of liver and liver tumours in thorium-dioxide patients.
Acta Pathol Microbiol Scand A. 1972;80(1):97-108. doi: 10.1111/j.1699-0463.1972.tb00274.x.
10
Thorotrast-induced liver neoplasia: a collective review.钍造影剂诱发的肝脏肿瘤形成:一项综合综述。
J Am Coll Surg. 2002 Nov;195(5):713-8. doi: 10.1016/s1072-7515(02)01287-5.

引用本文的文献

1
Metachronous Hepatic Angiosarcoma Presenting as a Mimic of Recurrent Hepatocellular Carcinoma.
J Gastrointest Cancer. 2019 Sep;50(3):647-650. doi: 10.1007/s12029-018-0094-3.
2
Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation.肝脏肝细胞癌与胆管癌合并:超声、CT、血管造影及碘油CT与病理对照
Abdom Imaging. 1994 Jan-Feb;19(1):43-6. doi: 10.1007/BF02165860.
3
Multiple malignant neoplasms 40 years after angiography with Thorotrast.使用钍造影剂血管造影40年后出现多发性恶性肿瘤。
Can Med Assoc J. 1983 Feb 1;128(3):289-92.